VeriMomIst borago officinalis leaf extract in der Schwangerschaft sicher?
No EU Cosmetic Regulation ban (Annex II) or Annex III restriction or harmonised CLP H360/H361 was identified for Borago officinalis leaf extract. However, the plant family (Boraginaceae) is known to produce pyrrolizidine alkaloids (PAs) which have demonstrated toxic and genotoxic mechanisms in animals and humans; this represents a class-based concern (h=1) with a demonstrated mechanism (m=2). Topical cosmetic use of a leaf extract is likely low but measurable exposure (e=1). Sources: EU INCI listing for Borago Officinalis Extract, PubMed reviews on borage/PAs, and EWG ingredient summary.
Schwangerschaftssichere Alternativen zu borago officinalis leaf extract | VeriMom
Related ingredients
Frequently asked questions
- Ist borago officinalis leaf extract in der Schwangerschaft sicher?
- No EU Cosmetic Regulation ban (Annex II) or Annex III restriction or harmonised CLP H360/H361 was identified for Borago officinalis leaf extract. However, the plant family (Boraginaceae) is known to produce pyrrolizidine alkaloids (PAs) which have demonstrated toxic and genotoxic mechanisms in animals and humans; this represents a class-based concern (h=1) with a demonstrated mechanism (m=2). Topical cosmetic use of a leaf extract is likely low but measurable exposure (e=1). Sources: EU INCI listing for Borago Officinalis Extract, PubMed reviews on borage/PAs, and EWG ingredient summary.
- Ist borago officinalis leaf extract während des Stillens sicher?
- Same rationale as pregnancy: no regulatory ban or harmonised reproductive classification found, but PA-related hepatotoxic/genotoxic concerns for Borago officinalis warrant a class-level caution (h=1). Mechanistic evidence for PA toxicity exists (m=2). Topical use implies low but measurable exposure (e=1); systemic transfer into breastmilk after dermal cosmetic use has not been demonstrated.
- Ist borago officinalis leaf extract sicher für Babyhaut?
- Hazard (h=1) remains driven by the plant’s PA class concern rather than any infant-specific reproductive data. Mechanistic concern from PAs (m=2) remains. Exposure is increased for babies (elevated by +1 to e=2) because infant skin has higher surface-area-to-weight and an immature barrier, so topical absorption (if any) is proportionally higher even though absolute systemic exposure from a cosmetic extract is expected to be low.
- Wie bewertet VeriMom borago officinalis leaf extract?
- VeriMom bewertet borago officinalis leaf extract mit 60/100 (mittleres Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu borago officinalis leaf extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu borago officinalis leaf extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.